Shopping Cart 0
Cart Subtotal
USD 0

Centogene AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier screening, and non-invasive prenatal testing. Centogene provides targeted services such as hereditary mutations for oncogenetics, somatic mutations for oncogenetics, male and female infertility testing panel, genetic testing of newborns and mitochondrial disease testing. The company's digital services include CentoCloud bioinformatics solution, a service designed for human genetic laboratories to support next generation sequencing diagnostics; and CentoMD mutation database. It has operational presence in Germany, Austria, India and the UAE. Centogene is headquartered in Rostock, Germany.

Centogene AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Centogene AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Centogene AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Centogene AG, Medical Devices Deals, 2012 to YTD 2018 9

Centogene AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Centogene AG, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Centogene Raises USD28 Million in Series A Financing 11

Partnerships 12

Centogene and Denali Therapeutics Enter into Agreement 12

Centogene and Evotec Enter into Co-Development Agreement 13

Centogene Enters into Agreement with Aldeyra Therapeutics 14

Centogene Enters into Agreement with Orphazyme 15

Centogene Partners with Filgen 16

Centogene Partners with Mikrogen 17

Asset Transactions 18

LifeLabs Medical Labs Acquires Genteic Testing Business Of Centogene 18

Centogene AG-Key Competitors 19

Centogene AG-Key Employees 20

Centogene AG-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Corporate Communications 22

May 04, 2018: CENTOGENE Appoints Berndt Modig as New Supervisory Board Member 22

Apr 10, 2018: CENTOGENE Expands Executive Team, Appoints Dr. Dirk Ehlers Chief Operating Officer 23

Legal and Regulatory 24

Oct 04, 2017: CENTOGENE received the Continuation of Accreditation Notice for the CAP 15189 Accreditation Program 24

Jan 27, 2017: CENTOGENE successfully renewed accreditation from College of American Pathologists 25

Other Significant Developments 26

Feb 28, 2018: CENTOGENE's "50+new genes" initiative-"Un-Rare" rare diseases 26

Jan 31, 2018: CENTOGENE Surpasses One Billion Identified Alleles within World's Largest Patient Database of Rare Genetic Disorders 27

May 05, 2017: Another milestone is reached for the new headquarter in Rostock 28

Feb 02, 2017: Centogene: Our new headquarter is growing rapidly 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Centogene AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Centogene AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Centogene AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Centogene AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Centogene AG, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Centogene AG, Pharmaceuticals & Healthcare, Key Facts 2

Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Centogene AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Centogene AG, Deals By Therapy Area, 2012 to YTD 2018 8

Centogene AG, Medical Devices Deals, 2012 to YTD 2018 9

Centogene AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Centogene Raises USD28 Million in Series A Financing 11

Centogene and Denali Therapeutics Enter into Agreement 12

Centogene and Evotec Enter into Co-Development Agreement 13

Centogene Enters into Agreement with Aldeyra Therapeutics 14

Centogene Enters into Agreement with Orphazyme 15

Centogene Partners with Filgen 16

Centogene Partners with Mikrogen 17

LifeLabs Medical Labs Acquires Genteic Testing Business Of Centogene 18

Centogene AG, Key Competitors 19

Centogene AG, Key Employees 20

Centogene AG, Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Centogene AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.